<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.0 20040830//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.0?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Scand J Immunol</journal-id>
      <journal-id journal-id-type="publisher-id">sji</journal-id>
      <journal-title-group>
        <journal-title>Scandinavian Journal of Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0300-9475</issn>
      <issn pub-type="epub">1365-3083</issn>
      <publisher>
        <publisher-name>Blackwell Publishing Ltd</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2784904</article-id>
      <article-id pub-id-type="pmid">19751267</article-id>
      <article-id pub-id-type="doi">10.1111/j.1365-3083.2009.02308.x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Discussion Forums</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>How do Regulatory T Cells Work?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Corthay</surname>
            <given-names>A</given-names>
          </name>
        </contrib>
        <aff>
          <institution>Centre for Immune Regulation, Institute of Immunology, University of Oslo and Oslo University Hospital</institution>
          <addr-line>Rikshospitalet, Oslo, Norway</addr-line>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to: A Corthay, University of Oslo, Institute of Immunology, Rikshospitalet, 0027 Oslo, Norway. E-mail: <email>alexandre.corthay@medisin.uio.no</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2009</year>
      </pub-date>
      <volume>70</volume>
      <issue>4</issue>
      <fpage>326</fpage>
      <lpage>336</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>2</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>27</day>
          <month>6</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Journal compilation &#xA9; 2009 Blackwell Publishing Ltd</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>CD4<sup>+</sup> T cells are commonly divided into regulatory T (Treg) cells and conventional T helper (Th) cells. Th cells control adaptive immunity against pathogens and cancer by activating other effector immune cells. Treg cells are defined as CD4<sup>+</sup> T cells in charge of suppressing potentially deleterious activities of Th cells. This review briefly summarizes the current knowledge in the Treg field and defines some key questions that remain to be answered. Suggested functions for Treg cells include: prevention of autoimmune diseases by maintaining self-tolerance; suppression of allergy, asthma and pathogen-induced immunopathology; feto-maternal tolerance; and oral tolerance. Identification of Treg cells remains problematic, because accumulating evidence suggests that all the presently-used Treg markers (CD25, CTLA-4, GITR, LAG-3, CD127 and Foxp3) represent general T-cell activation markers, rather than being truly Treg-specific. Treg-cell activation is antigen-specific, which implies that suppressive activities of Treg cells are antigen-dependent. It has been proposed that Treg cells would be self-reactive, but extensive TCR repertoire analysis suggests that self-reactivity may be the exception rather than the rule. The classification of Treg cells as a separate lineage remains controversial because the ability to suppress is not an exclusive Treg property. Suppressive activities attributed to Treg cells may in reality, at least in some experimental settings, be exerted by conventional Th cell subsets, such as Th1, Th2, Th17 and T follicular (Tfh) cells. Recent reports have also demonstrated that Foxp3<sup>+</sup> Treg cells may differentiate <italic>in vivo</italic> into conventional effector Th cells, with or without concomitant downregulation of Foxp3.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>The concept of suppression mediated by T cells is nearly as old as the discovery of T cells as a separate lineage of lymphocytes. Already in the early 1970s, it was proposed that suppressor T cells would be capable of inhibiting other T cells, and thereby mediate immunological tolerance and self/non-self discrimination [<xref ref-type="bibr" rid="b1">1</xref>&#x2013;<xref ref-type="bibr" rid="b3">3</xref>]. Suppressor T cells, which were characterized by expression of the CD8 (Lyt-2) cell surface marker, have been the topic of more than 1000 scientific publications. However, the existence of suppressor T cells as a distinct lineage of T cells has been very controversial [<xref ref-type="bibr" rid="b4">4</xref>]. In fact, the concept of suppressor T cells was largely abandoned by the end of the 1980s, essentially because of the poor characterization of the cells and the lack of specific markers [<xref ref-type="bibr" rid="b4">4</xref>, <xref ref-type="bibr" rid="b5">5</xref>].</p>
      <p>In the mid-1990s, a new subpopulation of suppressor T cells was proposed which expressed CD4 and which was named regulatory T (Treg) cells [<xref ref-type="bibr" rid="b5">5</xref>]. Accordingly, CD4<sup>+</sup> T cells are now commonly divided into two distinct lineages: Treg cells and conventional T helper (Th) cells. Conventional Th cells control the adaptive immunity by activating, in an antigen-specific fashion, other effector cells such as CD8<sup>+</sup> cytotoxic T cells, B cells and macrophages. Treg cells are defined as T cells in charge of suppressing potentially deleterious activities of Th cells. Treg cells represent nowadays a large field of research and a long list of Treg-associated suppressive mechanisms have been reported [<xref ref-type="bibr" rid="b6">6</xref>, <xref ref-type="bibr" rid="b7">7</xref>]. However, many central aspects of Treg cell biology remain obscure and hotly debated [<xref ref-type="bibr" rid="b8">8</xref>&#x2013;<xref ref-type="bibr" rid="b18">18</xref>]. The present review will focus on CD4<sup>+</sup> Treg cells and will not discuss the older literature on the functionally-related suppressor T cells. My main objective is to briefly summarize the current knowledge in the Treg field and to define some key questions which remain to be answered. I also would like to encourage all readers interested in immunologic controversies to read and send contributions to the discussion forum of the <italic>Scandinavian Journal of Immunology</italic> [<xref ref-type="bibr" rid="b14">14</xref>&#x2013;<xref ref-type="bibr" rid="b23">23</xref>]<italic>.</italic></p>
    </sec>
    <sec>
      <title>Seven key questions about Treg cells that remain to be answered</title>
      <sec>
        <title>What are the functions of Treg cells?</title>
        <p>The primary function of Treg cells was originally defined as prevention of autoimmune diseases by maintaining self-tolerance [<xref ref-type="bibr" rid="b24">24</xref>]. Over the years, several additional functions have been suggested and it will be important to clarify what Treg cells actually do in the immune system. Presently, at least 10 non-exclusive functions have been proposed for Treg cells (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>):</p>
        <fig id="fig01" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Five key questions about Treg cells. (A) What are the functions of Treg cells? (B) What molecular markers can be used to distinguish Treg cells from conventional Th cells? (C) Do Treg cells recognize self or non-self? (D) Do Treg cells represent a distinct lineage of CD4<sup>+</sup> T cells? (E) How do Treg cells know which Th cell to suppress? In other words, how do Treg cells discriminate between the bad (i.e. self-reactive) Th cells, which should be suppressed, and the good (i.e. virus-specific) Th cells which should not?</p>
          </caption>
          <graphic xlink:href="sji0070-0326-f1"/>
        </fig>
        <list list-type="order">
          <list-item>
            <p>Prevention of autoimmune diseases by establishing and maintaining immunologic self-tolerance [<xref ref-type="bibr" rid="b24">24</xref>&#x2013;<xref ref-type="bibr" rid="b27">27</xref>].</p>
          </list-item>
          <list-item>
            <p>Suppression of allergy and asthma [<xref ref-type="bibr" rid="b28">28</xref>&#x2013;<xref ref-type="bibr" rid="b30">30</xref>].</p>
          </list-item>
          <list-item>
            <p>Induction of tolerance against dietary antigens, i.e. oral tolerance [<xref ref-type="bibr" rid="b31">31</xref>&#x2013;<xref ref-type="bibr" rid="b34">34</xref>].</p>
          </list-item>
          <list-item>
            <p>Induction of maternal tolerance to the fetus [<xref ref-type="bibr" rid="b35">35</xref>].</p>
          </list-item>
          <list-item>
            <p>Suppression of pathogen-induced immunopathology [<xref ref-type="bibr" rid="b36">36</xref>&#x2013;<xref ref-type="bibr" rid="b38">38</xref>].</p>
          </list-item>
          <list-item>
            <p>Regulation of the effector class of the immune response [<xref ref-type="bibr" rid="b10">10</xref>, <xref ref-type="bibr" rid="b11">11</xref>].</p>
          </list-item>
          <list-item>
            <p>Suppression of T-cell activation triggered by weak stimuli [<xref ref-type="bibr" rid="b39">39</xref>].</p>
          </list-item>
          <list-item>
            <p>Feedback control of the magnitude of the immune response by effector Th cells [<xref ref-type="bibr" rid="b13">13</xref>, <xref ref-type="bibr" rid="b40">40</xref>].</p>
          </list-item>
          <list-item>
            <p>Protection of commensal bacteria from elimination by the immune system [<xref ref-type="bibr" rid="b14">14</xref>].</p>
          </list-item>
          <list-item>
            <p>Prevention of T cells that have been stimulated by their true high-affinity agonist ligand from killing cells that only express low-affinity T-cell receptor (TCR) ligands such as the self peptide-major histocompatibility complex (MHC) molecule that positively selected the T cell [<xref ref-type="bibr" rid="b16">16</xref>].</p>
          </list-item>
        </list>
        <p>It will be important to establish whether Treg cells are indeed performing all the above-listed functions. A related question is whether distinct subsets of Treg cells are responsible for the various suppressive activities.</p>
      </sec>
      <sec>
        <title>How to identify Treg cells?</title>
        <p>Molecular markers are essential tools for defining and for analyzing a subpopulation of immune cells. The collapse of the suppressor T cells at the end of the 1980s was largely due to the failure to define specific markers for these cells [<xref ref-type="bibr" rid="b4">4</xref>].</p>
        <p>The most widely used markers for Treg cells are (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>):</p>
        <list list-type="bullet">
          <list-item>
            <p>CD25 [<xref ref-type="bibr" rid="b24">24</xref>, <xref ref-type="bibr" rid="b41">41</xref>].</p>
          </list-item>
          <list-item>
            <p>cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) [<xref ref-type="bibr" rid="b42">42</xref>, <xref ref-type="bibr" rid="b43">43</xref>].</p>
          </list-item>
          <list-item>
            <p>glucocorticoid-induced tumour necrosis factor receptor family-related gene (GITR) [<xref ref-type="bibr" rid="b44">44</xref>].</p>
          </list-item>
          <list-item>
            <p>lymphocyte activation gene-3 (LAG-3) [<xref ref-type="bibr" rid="b45">45</xref>].</p>
          </list-item>
          <list-item>
            <p>CD127 [<xref ref-type="bibr" rid="b46">46</xref>, <xref ref-type="bibr" rid="b47">47</xref>].</p>
          </list-item>
          <list-item>
            <p>forkhead/winged-helix transcription factor box P3 (Foxp3) [<xref ref-type="bibr" rid="b48">48</xref>&#x2013;<xref ref-type="bibr" rid="b50">50</xref>].</p>
          </list-item>
        </list>
        <p>Unfortunately, accumulating evidence suggests that the above-listed markers are not strictly Treg-specific. Upon activation, all T cells express CD25, the &#x3B1;-chain of the interleukin-2 (IL-2) receptor [<xref ref-type="bibr" rid="b51">51</xref>&#x2013;<xref ref-type="bibr" rid="b53">53</xref>], IL-2 being a T-cell growth factor which is important for T-cell clonal expansion. CTLA-4 is a negative regulator of T-cell activation, which is upregulated on all CD4<sup>+</sup> and CD8<sup>+</sup> T cells, 2&#x2013;3 days following activation [<xref ref-type="bibr" rid="b52">52</xref>&#x2013;<xref ref-type="bibr" rid="b54">54</xref>]. Similarly, the expression of GITR [<xref ref-type="bibr" rid="b52">52</xref>, <xref ref-type="bibr" rid="b53">53</xref>, <xref ref-type="bibr" rid="b55">55</xref>] and LAG-3 [<xref ref-type="bibr" rid="b56">56</xref>, <xref ref-type="bibr" rid="b57">57</xref>] is induced in T cells upon activation. It has been suggested that CD127, the &#x3B1; chain of the IL-7 receptor, could be used to discriminate between CD127<sup>low</sup> Treg cells and CD127<sup>high</sup> conventional Th cells in humans [<xref ref-type="bibr" rid="b46">46</xref>, <xref ref-type="bibr" rid="b47">47</xref>]. However, it has been recently reported that most CD4<sup>+</sup> T cells downregulate CD127 upon activation [<xref ref-type="bibr" rid="b53">53</xref>, <xref ref-type="bibr" rid="b58">58</xref>]. Furthermore, loss of CD127 is a characteristic feature of T follicular helper (Tfh) cells, which provide help for B cells, in human tonsils [<xref ref-type="bibr" rid="b59">59</xref>]. It has been reported that na&#xEF;ve, CD25-negative mouse CD4<sup>+</sup> T cells do not upregulate Foxp3 when activated [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b50">50</xref>, <xref ref-type="bibr" rid="b60">60</xref>]. However, it is now well documented that most human CD4<sup>+</sup> and CD8<sup>+</sup> T cells transiently express Foxp3 upon activation [<xref ref-type="bibr" rid="b53">53</xref>, <xref ref-type="bibr" rid="b61">61</xref>&#x2013;<xref ref-type="bibr" rid="b65">65</xref>].</p>
        <p>In conclusion, all the presently-used Treg markers (CD25, CTLA-4, GITR, CD127, LAG-3 and Foxp3) appear to be general T-cell activation markers. This observation strongly suggests that T-cell activation is required for T-cell mediated suppression. However, it also implies that the current Treg markers are not truly Treg-specific and therefore are not reliable for distinguishing Treg cells from activated conventional Th cells.</p>
      </sec>
      <sec>
        <title>Is suppression by Treg cells antigen-specific?</title>
        <p>Treg cells, like all CD4<sup>+</sup> T cells, possess a somatically-rearranged TCR, which allows specific recognition of antigenic peptides in the context of MHC class II molecules. Activation of conventional Th cells requires specific antigen recognition by the TCR and one would expect Treg cells to follow the same rule. To clarify this issue, it is helpful to consider separately (1) the antigen specificity of the Treg cell itself and (2) the antigen specificity of the conventional Th cell that is suppressed by the Treg cell.</p>
        <p>Concerning the antigen specificity of the Treg cell itself, <italic>in vitro</italic> experiments have demonstrated that Treg cells need to be first activated via the TCR to become suppressive [<xref ref-type="bibr" rid="b66">66</xref>, <xref ref-type="bibr" rid="b67">67</xref>], although this has been contested by others [<xref ref-type="bibr" rid="b68">68</xref>]. This implies that (1) Treg-cell activation is antigen-specific; and (2) the suppressive activity of Treg cells is triggered in an antigen-specific fashion. The same requirement for antigen seems to apply for Treg functions <italic>in vivo</italic>, since the proliferation of Treg cells in lymph nodes was shown to be antigen-dependent [<xref ref-type="bibr" rid="b52">52</xref>]. Furthermore, in the experimental autoimmune encephalomyelitis (EAE) mouse model for multiple sclerosis, myelin basic protein (MBP)-specific Treg cells were detected and protection was associated with specificity for MBP [<xref ref-type="bibr" rid="b69">69</xref>]. In the non-obese diabetic mouse model for type 1 diabetes, Treg cells specific for a pancreatic autoantigen were much more efficient at preventing diabetes than polyclonal Treg cells [<xref ref-type="bibr" rid="b70">70</xref>, <xref ref-type="bibr" rid="b71">71</xref>]. It was further shown that pancreas-specific Treg cells could only prevent diabetes when the Treg antigen was present <italic>in vivo</italic> in the pancreas [<xref ref-type="bibr" rid="b72">72</xref>]. Finally, destructive autoimmune gastritis could be prevented by transfer of stomach-specific Treg cells, but not with polyclonal Treg cells [<xref ref-type="bibr" rid="b73">73</xref>].</p>
        <p>Concerning the antigen specificity of the conventional Th cell that is suppressed by the Treg cell, the key question here is whether the Treg cell and the Th cell need to recognize the same antigen or not. <italic>In vitro</italic> mixed-cultures experiments have demonstrated that Treg cells activated by their cognate antigen can suppress the proliferation of conventional Th cells with different antigen specificities [<xref ref-type="bibr" rid="b66">66</xref>, <xref ref-type="bibr" rid="b67">67</xref>]. <italic>In vivo</italic>, there is also evidence that Treg cells may suppress Th cells with other antigen specificities [<xref ref-type="bibr" rid="b71">71</xref>, <xref ref-type="bibr" rid="b74">74</xref>, <xref ref-type="bibr" rid="b75">75</xref>]. However, the issue is not settled yet, because there are also reports of antigen-specific suppression by Treg cell <italic>in vivo</italic> [<xref ref-type="bibr" rid="b75">75</xref>&#x2013;<xref ref-type="bibr" rid="b77">77</xref>]. For instance, Treg cells specific for proteolipid protein (PLP) peptide PLP139-151 could prevent EAE induced by the same peptide or by another peptide (PLP178-191) from the same antigen [<xref ref-type="bibr" rid="b75">75</xref>]. By contrast, PLP-specific Treg cells were unable to prevent EAE induced by other immunogens such as myelin basic protein (MBP) or myelin oligodendrocyte glycoprotein (MOG). These results indicate that the suppressive functions by Treg cells may operate in an antigen-restricted manner <italic>in vivo</italic>.</p>
        <p>In summary, suppression mediated by Treg cells is clearly antigen-dependent. The activation of Treg cells is antigen-specific, which implies that the suppressive activity of Treg cells is triggered in an antigen-specific fashion. Concerning the target cell, there is evidence that Treg cells may suppress Th cells with different antigen specificities. However, it is possible that suppression is more effective, and thereby physiologically more relevant, when the Treg cell and the suppressed Th cell have the same antigen specificity. To clarify these important issues, there is clearly a need for more <italic>in vivo</italic> studies with Treg cells with defined antigen specificities.</p>
      </sec>
      <sec>
        <title>Do Treg cells recognize self, non-self or both?</title>
        <p>The ability to discriminate between self and non-self is a central property of conventional Th cells. During T-cell thymic development, TCRs are generated stochastically by somatic gene rearrangements. To prevent autoimmunity, T cells with self-reactive TCRs are purged from the repertoire by depletion [<xref ref-type="bibr" rid="b78">78</xref>] or functional inactivation, also called <italic>anergy</italic> [<xref ref-type="bibr" rid="b79">79</xref>]. Thus, the conventional Th repertoire is being selected for recognition of non-self [<xref ref-type="bibr" rid="b19">19</xref>]. What do Treg cells recognize: self, non-self or both (<xref ref-type="fig" rid="fig01">Fig. 1C</xref>)?</p>
        <p>It has been proposed that Treg cells, which are in charge of maintaining self-tolerance, would be self-reactive [<xref ref-type="bibr" rid="b67">67</xref>]. Supporting this hypothesis, self-reactive Treg cells have been observed in various mouse models for autoimmune diseases. For instance, Treg cells specific for the insulin B chain [<xref ref-type="bibr" rid="b74">74</xref>] or for a pancreatic islet autoantigen [<xref ref-type="bibr" rid="b71">71</xref>, <xref ref-type="bibr" rid="b72">72</xref>] protected against type 1 diabetes. Furthermore, the presence of MBP-specific [<xref ref-type="bibr" rid="b69">69</xref>] or PLP-specific [<xref ref-type="bibr" rid="b75">75</xref>] Treg cells was associated with prevention of EAE. However, the self-reactivity of the Treg repertoire has been challenged by reports of Treg cells recognizing foreign antigens from bacteria [<xref ref-type="bibr" rid="b38">38</xref>, <xref ref-type="bibr" rid="b80">80</xref>], fungi [<xref ref-type="bibr" rid="b81">81</xref>], the protozoan parasite <italic>Leishmania major</italic> [<xref ref-type="bibr" rid="b82">82</xref>, <xref ref-type="bibr" rid="b83">83</xref>], allergens [<xref ref-type="bibr" rid="b30">30</xref>] and alloantigens [<xref ref-type="bibr" rid="b84">84</xref>, <xref ref-type="bibr" rid="b85">85</xref>].</p>
        <p>It has been suggested that Treg cells would be generated in the thymus from precursor cells with a high affinity TCR for a self peptide. This hypothesis has received support from experiments with TCR-transgenic mice [<xref ref-type="bibr" rid="b86">86</xref>&#x2013;<xref ref-type="bibr" rid="b88">88</xref>]. However, the interpretation of the data has been questioned by another report showing that the differentiation of Treg cells was not induced by a self-agonist ligand expressed in the thymus [<xref ref-type="bibr" rid="b89">89</xref>].</p>
        <p>Several attempts have been made to measure the diversity and specificity of the TCR repertoire expressed by Treg cells. These studies, all based on gene-manipulated mice with a limited TCR repertoire, revealed a considerable (10&#x2013;70%) overlap between the TCRs used by Treg cells and na&#xEF;ve Th cells [<xref ref-type="bibr" rid="b90">90</xref>&#x2013;<xref ref-type="bibr" rid="b93">93</xref>]. Initial studies of the Treg repertoire, which focused on the most frequently found TCRs, concluded that CD25<sup>+</sup> CD4<sup>+</sup> Treg cells exhibit a high frequency of TCRs specific for self peptides [<xref ref-type="bibr" rid="b90">90</xref>, <xref ref-type="bibr" rid="b91">91</xref>]. However, more recently, a much larger analysis of hundreds of TCRs, including infrequently used TCRs, found little evidence that the Treg population preferably recognized self antigens [<xref ref-type="bibr" rid="b93">93</xref>]. It was concluded that non-self antigens are the cognate specificities of Treg cells [<xref ref-type="bibr" rid="b93">93</xref>, <xref ref-type="bibr" rid="b94">94</xref>]. Collectively, these data suggest that self-reactivity may be the exception rather than the rule in the Treg repertoire, as it is for conventional Th cells.</p>
      </sec>
      <sec>
        <title>Do Treg cells represent a distinct lineage of CD4<sup>+</sup> T cells?</title>
        <p>How strong is the case for classifying Treg cells as a separate lineage of CD4<sup>+</sup> T cells distinct from conventional Th cells (<xref ref-type="fig" rid="fig01">Fig. 1D</xref>)? This issue may be considered either in terms of molecular markers or in functional terms. As discussed above, a truly Treg-specific molecular marker is still lacking. As a substitute, can biological activities be used to define the Treg lineage?</p>
        <p>Functionally, Treg cells are characterized by being suppressor cells which only suppress and do not activate other Th cells. One could wonder whether Treg cells represent the only CD4<sup>+</sup> T cells with suppressive functions. The answer to this question is clearly negative. The existence of four distinct subsets of conventional Th cells, which differ in terms of cytokine production and function, has now been firmly established: Th1 [<xref ref-type="bibr" rid="b95">95</xref>], Th2 [<xref ref-type="bibr" rid="b95">95</xref>], Th17 cells [<xref ref-type="bibr" rid="b96">96</xref>, <xref ref-type="bibr" rid="b97">97</xref>] and T follicular helper (Tfh) cells [<xref ref-type="bibr" rid="b98">98</xref>, <xref ref-type="bibr" rid="b99">99</xref>]. Conventional Th cells control the adaptive immunity by activating other effector cells such as CD8<sup>+</sup> cytotoxic T cells, B cells and macrophages. However, effector Th cell subsets have also been shown to suppress each other. For instance, Th1 cells secrete interferon-&#x3B3; (IFN-&#x3B3;) that inhibits the proliferation of Th2 cells [<xref ref-type="bibr" rid="b100">100</xref>, <xref ref-type="bibr" rid="b101">101</xref>]. IL-4, which is produced by Th2 cells, suppresses Th1 development and secretion of IFN-&#x3B3; by Th1 cells [<xref ref-type="bibr" rid="b102">102</xref>, <xref ref-type="bibr" rid="b103">103</xref>]. Both IFN-&#x3B3; and IL-4 inhibit Th17 differentiation and the production of IL-17 by effector Th17 cells [<xref ref-type="bibr" rid="b96">96</xref>, <xref ref-type="bibr" rid="b97">97</xref>]. IL-17, which is secreted by Th17 cells, suppresses Th1 differentiation and was recently shown to protect mice from Th1-driven colitis [<xref ref-type="bibr" rid="b104">104</xref>]. IL-21, which is produced by Th2, Th17 and Tfh cells, inhibits the differentiation of Th1 cells [<xref ref-type="bibr" rid="b105">105</xref>]. Th1, Th2 and Th17 cells may all produce IL-10, which suppresses proliferation and cytokine production by various T-cell subsets [<xref ref-type="bibr" rid="b12">12</xref>, <xref ref-type="bibr" rid="b106">106</xref>&#x2013;<xref ref-type="bibr" rid="b110">110</xref>]. Thus, the ability to suppress T cells is clearly not an exclusive property of Treg cells and all CD4<sup>+</sup> T cells appear to exert various kinds of suppressive activities. Therefore, the key question is whether there is a special CD4<sup>+</sup> T cell lineage, the Treg cells, which is dedicated to suppression, while conventional Th cells can both activate and suppress other T cells.</p>
        <p>Transforming growth factor &#x3B2; (TGF-&#x3B2;) is produced by some Treg cells and has been suggested to be an important mediator of Treg-mediated suppression in the gut [<xref ref-type="bibr" rid="b111">111</xref>]. TGF-&#x3B2; may act as an immunosuppressive cytokine which for example inhibits the secretion of immunoglobulin (Ig) M, IgG1, IgG2a and IgG3 [<xref ref-type="bibr" rid="b112">112</xref>]. However, TGF-&#x3B2; can also be immunostimulatory. In particular, TGF-&#x3B2; has been shown to specifically induce IgA [<xref ref-type="bibr" rid="b112">112</xref>&#x2013;<xref ref-type="bibr" rid="b114">114</xref>] and IgG2b [<xref ref-type="bibr" rid="b115">115</xref>] isotype switch in B cells. It has been proposed that TGF&#x3B2;-producing CD4<sup>+</sup> T cells may represent another Th subset (Th3) with both mucosal Th function and downregulatory properties for Th1 cells [<xref ref-type="bibr" rid="b31">31</xref>, <xref ref-type="bibr" rid="b32">32</xref>]. Thus, the main role of TGF-&#x3B2;-secreting CD4<sup>+</sup> T cells in mucosal regions may be to function as Tfh cells and to help B cells to produce IgA, rather than to exclusively immunosuppress. In humans, it has also been proposed that Treg cells producing both TGF-&#x3B2; and IL-10 may induce B cells to secrete IgG4 [<xref ref-type="bibr" rid="b116">116</xref>].</p>
        <p>The concept that Treg cells would represent a distinct T-cell lineage with &#x2018;suppressor only&#x2019; activities has been further challenged by recent studies demonstrating that Foxp3<sup>+</sup> Treg cells in human peripheral blood and tonsils had the capacity to produce IL-17 upon activation [<xref ref-type="bibr" rid="b117">117</xref>&#x2013;<xref ref-type="bibr" rid="b119">119</xref>]. IL-17 is a proinflammatory cytokine, which is typically produced by Th17 cells and which is believed to be important for immunity against extracellular bacteria [<xref ref-type="bibr" rid="b96">96</xref>, <xref ref-type="bibr" rid="b97">97</xref>]. Like conventional Treg cells, IL-17&#x2013;producing Treg cells strongly suppressed responder Th cell proliferation [<xref ref-type="bibr" rid="b117">117</xref>&#x2013;<xref ref-type="bibr" rid="b119">119</xref>]. Foxp3<sup>+</sup> Treg cells produced IL-17 when activated in the presence of the proinflammatory cytokines IL-1&#x3B2; and IL-6, whereas IL-17 secretion was inhibited by TGF-&#x3B2; [<xref ref-type="bibr" rid="b118">118</xref>]. IL-17<sup>+</sup> Foxp3<sup>+</sup> Treg clones were plastic enough to either secrete IL-17 or suppress, depending on the nature of the stimulus provided [<xref ref-type="bibr" rid="b118">118</xref>]. Collectively, these data suggest that the suppressive activities attributed to Treg cells may in reality, at least in some experimental settings, be exerted by conventional Th cell subsets such as Tfh and Th17 cells.</p>
      </sec>
      <sec>
        <title>What is the function of Foxp3?</title>
        <p>The Foxp3 transcription factor is considered the most reliable marker for Treg cells [<xref ref-type="bibr" rid="b48">48</xref>&#x2013;<xref ref-type="bibr" rid="b50">50</xref>, <xref ref-type="bibr" rid="b60">60</xref>]. Tissue distribution analysis has shown that Foxp3 is mostly present in lymphoid tissues [<xref ref-type="bibr" rid="b120">120</xref>]. The expression of Foxp3 is highly restricted to &#x3B1;&#x3B2; T cells, and almost undetectable in B cells, &#x3B3;&#x3B4; T cells, natural killer (NK) cells, macrophages and dendritic cells (DC) [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b49">49</xref>, <xref ref-type="bibr" rid="b60">60</xref>, <xref ref-type="bibr" rid="b120">120</xref>, <xref ref-type="bibr" rid="b121">121</xref>]. The expression of Foxp3 is mostly restricted to CD4<sup>+</sup> T cells, but some CD8<sup>+</sup> T cells do express Foxp3 as well [<xref ref-type="bibr" rid="b60">60</xref>]. Contradictory data have been published on whether Foxp3 can be expressed by murine Th1 and Th2 cells [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b120">120</xref>]. There is an imperfect overlap between the expression of Foxp3 and that of CD25, the classical marker for Treg cells. In mice, Foxp3 could be detected in both CD4<sup>+</sup> CD25<sup>+</sup> and CD4<sup>+</sup> CD25<sup>&#x2212;</sup> T cells, but it was much more abundant in CD4<sup>+</sup> CD25<sup>+</sup> T cells [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b49">49</xref>]. In the lymph nodes and spleen, most CD4<sup>+</sup> CD25<sup>+</sup> T cells expressed Foxp3, but there was also a population of Foxp3<sup>+</sup> CD4<sup>+</sup> T cells, which did not express CD25 [<xref ref-type="bibr" rid="b60">60</xref>, <xref ref-type="bibr" rid="b121">121</xref>]. In the lungs, most Foxp3<sup>+</sup> CD4<sup>+</sup> T cells were negative for CD25 [<xref ref-type="bibr" rid="b60">60</xref>].</p>
        <p>Foxp3 was originally suspected to be important for Treg functions because mutations in Foxp3 were found to be the cause of two severe multiorgan autoimmune syndromes in humans, namely XLAAD (X-linked autoimmunity-allergic dysregulation syndrome) and IPEX (immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) [<xref ref-type="bibr" rid="b122">122</xref>&#x2013;<xref ref-type="bibr" rid="b124">124</xref>]. Similarly, mutant <italic>scurfy</italic> mice with a disrupted Foxp3 gene develop a fatal lymphoproliferative disorder and die within 4 weeks after birth [<xref ref-type="bibr" rid="b120">120</xref>]. T cell-specific ablation of Foxp3 resulted in a lymphoproliferative autoimmune syndrome identical to that observed in Foxp3-deficient mice [<xref ref-type="bibr" rid="b60">60</xref>]. Thus, Foxp3 is clearly essential for T-cell functions and defective Foxp3 leads to lethal immune dysregulation. However, association between a defective gene and severe immunopathology does not necessarily imply that the gene is specific for a distinct T-cell subset dedicated to immunosuppression. Mice lacking other key immunoregulatory molecules such as CTLA-4 [<xref ref-type="bibr" rid="b125">125</xref>, <xref ref-type="bibr" rid="b126">126</xref>], TGF-&#x3B2; [<xref ref-type="bibr" rid="b127">127</xref>] and TGF-&#x3B2; receptor on T cells [<xref ref-type="bibr" rid="b128">128</xref>], all exhibit lethal lymphoproliferative phenotypes very similar to Foxp3-deficient mice.</p>
        <p>Foxp3 was initially suggested to represent the &#x2018;master regulator&#x2019; or &#x2018;lineage-specification factor&#x2019; for the development of Treg cells [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b49">49</xref>, <xref ref-type="bibr" rid="b60">60</xref>], but this hypothesis has been challenged [<xref ref-type="bibr" rid="b129">129</xref>]. Experiments with mice expressing a fusion protein of non-functional Foxp3 and green fluorescent protein suggested that Foxp3 may be required for Treg functions but not for lineage commitment [<xref ref-type="bibr" rid="b130">130</xref>, <xref ref-type="bibr" rid="b131">131</xref>]. Another study concluded that a higher level of regulation upstream of Foxp3 determines the Treg lineage [<xref ref-type="bibr" rid="b132">132</xref>]. Rather than being the &#x2018;master regulator&#x2019; for the Treg lineage, it has been proposed that the function of Foxp3 would be to amplify and fix pre-established molecular features of Treg cells [<xref ref-type="bibr" rid="b130">130</xref>]. Continuous Foxp3 expression has been reported to be essential for maintenance of the developmentally established suppressive program in mature Treg cells in the periphery [<xref ref-type="bibr" rid="b133">133</xref>]. It has been suggested that expression of Foxp3 must be stabilized by epigenetic modification such as demethylation to allow the development of a permanent Treg cell lineage [<xref ref-type="bibr" rid="b134">134</xref>&#x2013;<xref ref-type="bibr" rid="b136">136</xref>].</p>
        <p>Although Foxp3 is a transcription factor, its exact function remains largely unknown. It has been suggested that Foxp3 may act as a repressor of transcription with the function of regulating the amplitude of the response of CD4<sup>+</sup> T cells to activation [<xref ref-type="bibr" rid="b137">137</xref>]. It has also been proposed that all human CD4<sup>+</sup> and CD8<sup>+</sup> T cells may upregulate Foxp3 and acquire suppressive properties upon activation [<xref ref-type="bibr" rid="b65">65</xref>]. Genome-wide analysis has shown that Foxp3 binds to the promoter region of 700&#x2013;1100 genes, many of those genes being associated with TCR signalling [<xref ref-type="bibr" rid="b138">138</xref>, <xref ref-type="bibr" rid="b139">139</xref>]. A large number of Foxp3-bound genes were up- or down-regulated in Foxp3<sup>+</sup> T cells, indicating that Foxp3 may act as both a transcriptional activator and repressor [<xref ref-type="bibr" rid="b138">138</xref>, <xref ref-type="bibr" rid="b139">139</xref>].</p>
        <p>The main evidence supporting Foxp3 as a critical factor for Treg functions comes from experiments showing that na&#xEF;ve T cells could be rendered suppressive by retroviral gene transfer of Foxp3 [<xref ref-type="bibr" rid="b48">48</xref>, <xref ref-type="bibr" rid="b49">49</xref>]. However, in some experimental settings, Foxp3 did not seem to be absolutely required for suppressive activity. For instance, Treg cells generated <italic>in vivo</italic> by prolonged exposure to a harmless antigen did not express significant Foxp3 mRNA [<xref ref-type="bibr" rid="b140">140</xref>]. Similarly, Foxp3 was not expressed by T regulatory cells 1 (Tr1), a Treg subset which is induced by IL-10 and which produces IL-10 [<xref ref-type="bibr" rid="b141">141</xref>&#x2013;<xref ref-type="bibr" rid="b143">143</xref>]. Furthermore, Foxp3 was not found in CD69<sup>+</sup> CD25<sup>&#x2212;</sup> Treg cells isolated from tumour-bearing mice [<xref ref-type="bibr" rid="b144">144</xref>].</p>
        <p>The idea of Treg-restricted expression of Foxp3 was challenged by experiments on the role of Treg cells during viral infections in mice. Treg cells have been suggested to suppress virus-specific immune responses to prevent immunopathology caused by excessive immune responses [<xref ref-type="bibr" rid="b36">36</xref>&#x2013;<xref ref-type="bibr" rid="b38">38</xref>]. Surprisingly, depletion of Foxp3<sup>+</sup> T cells resulted in impaired rather than increased immunity against herpes simplex virus and lymphocytic choriomeningitis virus [<xref ref-type="bibr" rid="b145">145</xref>]. These results suggest that Foxp3 may be expressed by a subset of effector T cells required for virus clearance [<xref ref-type="bibr" rid="b145">145</xref>]. In my opinion, these data on the antiviral function of Foxp3<sup>+</sup> T cells are clearly in contradiction with the nature of Treg cells which are defined as suppressor cells only.</p>
        <p>A series of recent reports has demonstrated that Foxp3<sup>+</sup> Treg cells may differentiate into conventional effector Th cells, with or without concomitant downregulation of Foxp3. Treg cells induced by TGF-&#x3B2;<italic>in vitro</italic> were shown to lose Foxp3 expression and suppressive activity upon restimulation in the absence of TGF-&#x3B2; [<xref ref-type="bibr" rid="b134">134</xref>]. Transfer experiments of labelled Foxp3<sup>+</sup> T cells into T-cell-deficient mice revealed that a large fraction (45&#x2013;80 %) of the Treg cells had lost Foxp3 expression 4 weeks after transfer [<xref ref-type="bibr" rid="b146">146</xref>&#x2013;<xref ref-type="bibr" rid="b148">148</xref>]. In the lymph nodes and spleen, some of the transferred Treg cells had differentiated into IFN-&#x3B3;-producing Th1, IL-4-producing Th2 cells and IL-17-producing Th17 cells [<xref ref-type="bibr" rid="b133">133</xref>, <xref ref-type="bibr" rid="b146">146</xref>, <xref ref-type="bibr" rid="b148">148</xref>], and induced lung inflammatory disease in recipient mice [<xref ref-type="bibr" rid="b148">148</xref>]. In the Peyer&#x2019;s patches, Foxp3<sup>+</sup> Treg cells efficiently downregulated Foxp3 and differentiated into Tfh cells that provided help for IgA production by B cells [<xref ref-type="bibr" rid="b147">147</xref>]. In mice, IL-12 was shown to induce IFN-&#x3B3; production by Foxp3<sup>+</sup> Treg cells <italic>in vitro</italic>, even while Foxp3 expression remained [<xref ref-type="bibr" rid="b149">149</xref>]. Furthermore, IL-6 induced Foxp3 downregulation in Treg cells and reprogrammed Treg cells to become Th17 cells [<xref ref-type="bibr" rid="b150">150</xref>, <xref ref-type="bibr" rid="b151">151</xref>]. As many as 25% of small intestinal Th17 cells had expressed Foxp3 at some stage of their development [<xref ref-type="bibr" rid="b152">152</xref>]. It has been proposed that Treg cells may differentiate into Th17 cells <italic>in vivo</italic> in the presence of inflammatory signals [<xref ref-type="bibr" rid="b151">151</xref>, <xref ref-type="bibr" rid="b152">152</xref>]. Notably, the existence of T cells co-expressing Foxp3 and IL-17 has been reported both in mice and in humans [<xref ref-type="bibr" rid="b117">117</xref>&#x2013;<xref ref-type="bibr" rid="b119">119</xref>, <xref ref-type="bibr" rid="b152">152</xref>, <xref ref-type="bibr" rid="b153">153</xref>]. Collectively, these data question the stability of the Treg cell lineage and suggest that Foxp3<sup>+</sup> T cells may represent Th cells that are not fully differentiated. Furthermore, accumulating evidence indicates that Foxp3 may be expressed by Th cells that produce proinflammatory cytokines such as IFN-&#x3B3; and IL-17.</p>
      </sec>
      <sec>
        <title>How do Treg cells know which Th cell to suppress?</title>
        <p>A major challenge for the Treg field is to understand how Treg cells discriminate between the bad (i.e. self-reactive) Th cells, which should be suppressed, and the good (i.e. virus-specific) Th cells, which should not (<xref ref-type="fig" rid="fig01">Fig. 1E</xref>). If this distinction is not made, the host will be immunosuppressed and succumb to microbial infection or cancer. Several models have been proposed to solve this conundrum.</p>
        <p>According to the <italic>crossregulation model</italic> proposed by Leon <italic>et al.</italic> [<xref ref-type="bibr" rid="b154">154</xref>, <xref ref-type="bibr" rid="b155">155</xref>], suppression by Treg cells is antigen-specific. In this model that has received some experimental support [<xref ref-type="bibr" rid="b75">75</xref>&#x2013;<xref ref-type="bibr" rid="b77">77</xref>], Treg cells are suggested to be autoreactive and to suppress conventional Th cells with the same antigen specificity. This allows Treg cells to mediate natural tolerance by ensuring self/non-self discrimination. The mechanism of suppression is proposed to be based on a three-partner interaction between the Treg cell, the Th cell to be suppressed, and the antigen-presenting cell (APC) [<xref ref-type="bibr" rid="b154">154</xref>, <xref ref-type="bibr" rid="b155">155</xref>].</p>
        <p>The <italic>TCR signal strength model</italic> by Baecher-Allan <italic>et al.</italic> [<xref ref-type="bibr" rid="b39">39</xref>] is based on the assumption that autoreactive T cells in the periphery have low-affinity TCRs because T cells expressing high-affinity TCRs for self antigens are deleted in the thymus. It is proposed that Treg cells suppress the physiologic activation of autoreactive T cells associated with low signal strength, while T cells activated during inflammatory responses associated with high signal strength are refractory to this mechanism of suppression [<xref ref-type="bibr" rid="b39">39</xref>]. This model was recently further developed by Beriou <italic>et al.</italic> who proposed that inflammation could drive Treg cells to lose suppressive activity and to secrete IL-17, thereby dampening suppression and promoting a pro-inflammatory milieu [<xref ref-type="bibr" rid="b118">118</xref>].</p>
        <p>During microbial infections, conserved pathogen-associated molecular patterns bind to Toll-like receptors (TLRs) on immune cells. According to the <italic>Toll-like receptor (TLR)-mediated blockade of Treg suppression model</italic> by Pasare and Medzhitov [<xref ref-type="bibr" rid="b156">156</xref>], TLR-mediated activation of DC results in blockade of the suppressive activity of Treg cells, thereby allowing activation of pathogen-specific adaptive immune responses [<xref ref-type="bibr" rid="b156">156</xref>]. A similar model has been proposed by Sutmuller <italic>et al.</italic> [<xref ref-type="bibr" rid="b157">157</xref>], in which Treg cells are directly inactivated during infections, when microbial products bind to TLR2 on the surface of the Treg cells. A main problem with these two TLR-based models is that they imply that immune responses against pathogens should always be associated with autoimmunity, since microbial infections inactivate Treg cells that are in charge of maintaining peripheral T-cell tolerance.</p>
        <p>Ingested antigens lead to the generation of Treg cells that secrete TGF-&#x3B2;, IL-4 and IL-10, rather than IFN-&#x3B3; and are capable of influencing na&#xEF;ve T cells in their immediate environment to do the same [<xref ref-type="bibr" rid="b31">31</xref>]. According to the <italic>effector class regulation model</italic> by Matzinger [<xref ref-type="bibr" rid="b10">10</xref>, <xref ref-type="bibr" rid="b11">11</xref>], DC can act as &#x2018;temporal bridges&#x2019; to relay information from orally immunized Treg cells to na&#xEF;ve CD4<sup>+</sup> T cells to regulate the effector class of the immune response. The orally immunized T cells use IL-4 and IL-10 to &#x2018;educate&#x2019; DC, which in turn induce na&#xEF;ve T cells to produce the same cytokines as those produced by the orally immunized Treg cells. In this model, conversion of a na&#xEF;ve T cell occurs only if it can interact with the same DC, although not necessarily the same antigen, as the Treg cell. According to Matzinger, Treg cells do not represent a separate lineage of CD4<sup>+</sup> T cells dedicated to suppression. Instead, Treg cells are proposed to correspond to new subsets of Th cells, which can both suppress and activate immune functions, such as IgA production by B cells [<xref ref-type="bibr" rid="b10">10</xref>, <xref ref-type="bibr" rid="b11">11</xref>].</p>
        <p>In an updated version of the <italic>associative recognition of antigen (ARA) model</italic>, Melvin Cohn [<xref ref-type="bibr" rid="b13">13</xref>] has recently proposed that Treg cells are not involved in self/non-self discrimination. Instead, the function of Treg cells (<italic>T suppressor</italic>) would be to feedback control the magnitude of immune responses by effector Th cells [<xref ref-type="bibr" rid="b13">13</xref>]. In this model, Treg cells are suggested to be specific for non-self and to suppress conventional Th cells with the same antigen specificity [<xref ref-type="bibr" rid="b13">13</xref>].</p>
      </sec>
    </sec>
    <sec>
      <title>Concluding remarks</title>
      <p>A major outcome of the intensive research efforts on Treg cells has been to revive interest for suppression mediated by T cells, a neglected research area after the collapse of the suppressor T-cell hypothesis at the end of the 1980s. T-cell mediated suppression was so disregarded that conventional Th cells were often considered erroneously as &#x2018;activators only&#x2019;. However, the stimulatory activities of T cells need to be counterbalanced by suppressive mechanisms, in order to fine-tune immune responses and to prevent immunopathology. Intrinsic negative feedback loops are critically involved in the activation of all T cells and mice deficient for key immunoregulatory molecules such as CTLA-4 exhibit lethal lymphoproliferative disease [<xref ref-type="bibr" rid="b125">125</xref>, <xref ref-type="bibr" rid="b126">126</xref>]. It is well established that conventional Th cell subsets suppress each other [<xref ref-type="bibr" rid="b96">96</xref>, <xref ref-type="bibr" rid="b97">97</xref>, <xref ref-type="bibr" rid="b100">100</xref>&#x2013;<xref ref-type="bibr" rid="b105">105</xref>]. More recently, several studies have started to uncover the importance of suppression mediated by effector Th cells during immune responses against pathogens. For instance, the significance of secretion by Th1 cells of the immunosuppressive cytokine IL-10 is being recognized. IFN-&#x3B3; is essential for control of many pathogens, but survival of the host often also depends on the secretion of IL-10. In mice infected by the protozoan parasite <italic>Toxoplasma gondii</italic>, it was found that essentially all of the IL-10 derived from conventional Th1 cells, the same cell population that displays effector function against the parasite [<xref ref-type="bibr" rid="b12">12</xref>]. Similarly, virus-specific Th1 cells were shown to exert simultaneously stimulatory (IFN-&#x3B3; production) and inhibitory (IL-10 secretion) functions during acute influenza infection [<xref ref-type="bibr" rid="b110">110</xref>]. IL-10 produced by influenza-specific Th1 cells had a crucial role in suppressing excess inflammation and associated immunopathology [<xref ref-type="bibr" rid="b110">110</xref>].</p>
      <p>In 1988, G&#xF6;ran M&#xF6;ller, who was one of the most respected and influential immunologists in Scandinavia, wrote for the <italic>Scandinavian Journal of Immunology</italic> an editorial entitled &#x2018;Do Suppressor T Cells Exist?&#x2019;. In this article, he summarized his point of view in one sentence: &#x2018;I am not questioning the existence of suppressive phenomena or findings that T cells can mediate suppressive effects, but I am skeptical of the notion of suppressor T cells as a separate subpopulation of T cells&#x2019;[<xref ref-type="bibr" rid="b4">4</xref>]. M&#xF6;ller&#x2019;s main argument to reject the concept of suppressor T cells was the lack of specific markers [<xref ref-type="bibr" rid="b4">4</xref>]. Time has passed and suppressor T cells have been renamed Treg cells [<xref ref-type="bibr" rid="b5">5</xref>]. It is undisputable that much has been learned about the mechanisms of suppression mediated by T cells, as testified in this review. However, it is striking to realize that we are still lacking a truly specific molecular marker for Treg cells, despite considerable research efforts. G&#xF6;ran M&#xF6;ller died last year [<xref ref-type="bibr" rid="b158">158</xref>, <xref ref-type="bibr" rid="b159">159</xref>] and one can therefore only speculate whether he would have written, 21 years later, a new editorial entitled: &#x2018;Do Regulatory T Cells Exist?&#x2019;.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p content-type="acknowledgment">I thank Colin C. Anderson, Ranveig Braathen, Ole Audun Werner Haabeth, Peter O. Hofgaard, Kristina Berg Lorvik, Ludvig A. Munthe, Pier A. Ruffini and Inger &#xD8;ynebr&#xE5;ten for critical reading of the manuscript. This work was supported by grants from the Norwegian Cancer Society, Anders Jahre&#x2019;s fund, stud. med. John Selmer Gulliksen&#x2019;s fund, S. G. S&#xF8;nneland foundation, H. G. og Andrine Berg og deres s&#xF8;nn Hans Gysler Berg&#x2019;s fund and Henrik Homans Minde&#x2019;s fund.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gershon</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Cell interactions in the induction of tolerance: the role of thymic lymphocytes</article-title>
          <source>Immunology</source>
          <year>1970</year>
          <volume>18</volume>
          <fpage>723</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">4911896</pub-id>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gershon</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Infectious immunological tolerance</article-title>
          <source>Immunology</source>
          <year>1971</year>
          <volume>21</volume>
          <fpage>903</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">4943147</pub-id>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gershon</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hencin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Liebhaber</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Suppressor T cells</article-title>
          <source>J Immunol</source>
          <year>1972</year>
          <volume>108</volume>
          <fpage>586</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">4401006</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moller</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Do suppressor T cells exist?</article-title>
          <source>Scand J Immunol</source>
          <year>1988</year>
          <volume>27</volume>
          <fpage>247</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">2965407</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakaguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wing</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Miyara</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cells &#x2013; a brief history and perspective</article-title>
          <source>Eur J Immunol</source>
          <year>2007</year>
          <volume>37</volume>
          <issue>Suppl. 1</issue>
          <fpage>S116</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">17972355</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sojka</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Fowell</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of regulatory T-cell suppression &#x2013; a diverse arsenal for a moving target</article-title>
          <source>Immunology</source>
          <year>2008</year>
          <volume>124</volume>
          <fpage>13</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">18346152</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Bluestone</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The Foxp3 + regulatory T cell: a jack of all trades, master of regulation</article-title>
          <source>Nat Immun</source>
          <year>2008</year>
          <volume>9</volume>
          <fpage>239</fpage>
          <lpage>44</lpage>
        </element-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stockinger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Barthlott</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kassiotis</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>T cell regulation: a special job or everyone&#x2019;s responsibility?</article-title>
          <source>Nat Immun</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>757</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zinkernagel</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>On cross-priming of MHC class I-specific CTL: rule or exception?</article-title>
          <source>Eur J Immunol</source>
          <year>2002</year>
          <volume>32</volume>
          <fpage>2385</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">12207322</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alpan</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bachelder</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Isil</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Arnheiter</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matzinger</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>&#x2018;Educated&#x2019; dendritic cells act as messengers from memory to naive T helper cells</article-title>
          <source>Nat Immun</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>615</fpage>
          <lpage>22</lpage>
        </element-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matzinger</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Friendly and dangerous signals: is the tissue in control?</article-title>
          <source>Nat Immun</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>11</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jankovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kullberg</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>CG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection</article-title>
          <source>J Exp Med</source>
          <year>2007</year>
          <volume>204</volume>
          <fpage>273</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="pmid">17283209</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>What roles do regulatory T cells play in the control of the adaptive immune response?</article-title>
          <source>Int Immunol</source>
          <year>2008</year>
          <volume>20</volume>
          <fpage>1107</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">18658168</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dembic</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Beginning of the end of (understanding) the immune response</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>381</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">18782266</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A reply to Dembic: on an end to the beginning of misunderstanding the immune response</article-title>
          <source>Scand J Immunol</source>
          <year>2009</year>
          <volume>69</volume>
          <fpage>302</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">19284493</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>Placing regulatory T cells into global theories of immunity: an analysis of Cohn&#x2019;s challenge to integrity (Dembic)</article-title>
          <source>Scand J Immunol</source>
          <year>2009</year>
          <volume>69</volume>
          <fpage>306</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19284494</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>On the critique by Colin Anderson of &#x201C;A Reply to Dembic: On an end to the beginning of mis-understanding the immune response&#x201D;</article-title>
          <source>Scand J Immunol</source>
          <year>2009</year>
          <volume>70</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19522761</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <article-title>On the sorting of the repertoire: An analysis of Cohn&#x2019;s challenge to integrity (Dembic), round 2</article-title>
          <source>Scand J Immunol</source>
          <year>2009</year>
          <comment>in press</comment>
        </element-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A rationalized set of default postulates that permit a coherent description of the immune system amenable to computer modeling</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>371</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">18782265</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunliffe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Intentional pathogen killing &#x2013; or denial of substrate?</article-title>
          <source>Scand J Immunol</source>
          <year>2007</year>
          <volume>66</volume>
          <fpage>604</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17949408</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagy</surname>
              <given-names>ZA</given-names>
            </name>
          </person-group>
          <article-title>Evolutionary origin of the immune system: a dialogue with Rod Langman</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>67</volume>
          <fpage>313</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">18266795</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunliffe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A proliferation of pathogens through the 20th century</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>120</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">18544150</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGonagle</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Georgouli</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The importance of &#x2018;Mechnikov&#x2019;s thorn&#x2019; for an improved understanding of 21st century medicine and immunology: a view from the eye</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>129</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">18510591</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakaguchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title>
          <source>J Immunol</source>
          <year>1995</year>
          <volume>155</volume>
          <fpage>1151</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">7636184</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes</article-title>
          <source>Scand J Immunol</source>
          <year>2007</year>
          <volume>66</volume>
          <fpage>515</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">17883389</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piao</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Jee</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>RL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IL-21 modulates CD4 + CD25 + regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>67</volume>
          <fpage>37</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">18052963</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>67</volume>
          <fpage>63</fpage>
          <lpage>70</lpage>
          <pub-id pub-id-type="pmid">18052965</pub-id>
        </element-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Curotto de Lafaille</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Muriglan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sunshine</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes</article-title>
          <source>J Exp Med</source>
          <year>2001</year>
          <volume>194</volume>
          <fpage>1349</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">11696599</pub-id>
        </element-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akbari</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>EH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>1024</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">12145647</pub-id>
        </element-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuany-Amorim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sawicka</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Manlius</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Suppression of airway eosinophilia by killed <italic>Mycobacterium vaccae</italic>-induced allergen-specific regulatory T-cells</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>625</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">12042815</pub-id>
        </element-citation>
      </ref>
      <ref id="b31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kuchroo</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Inobe</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hafler</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis</article-title>
          <source>Science</source>
          <year>1994</year>
          <volume>265</volume>
          <fpage>1237</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">7520605</pub-id>
        </element-citation>
      </ref>
      <ref id="b32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiner</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Oral tolerance: immune mechanisms and treatment of autoimmune diseases</article-title>
          <source>Immunol Today</source>
          <year>1997</year>
          <volume>18</volume>
          <fpage>335</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">9238837</pub-id>
        </element-citation>
      </ref>
      <ref id="b33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Izikson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Weiner</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration</article-title>
          <source>J Immunol</source>
          <year>2001</year>
          <volume>167</volume>
          <fpage>4245</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">11591746</pub-id>
        </element-citation>
      </ref>
      <ref id="b34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karlsson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Rugtveit</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Brandtzaeg</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Allergen-responsive CD4 + CD25 + regulatory T cells in children who have outgrown cow&#x2019;s milk allergy</article-title>
          <source>J Exp Med</source>
          <year>2004</year>
          <volume>199</volume>
          <fpage>1679</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">15197226</pub-id>
        </element-citation>
      </ref>
      <ref id="b35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aluvihare</surname>
              <given-names>VR</given-names>
            </name>
            <name>
              <surname>Kallikourdis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Betz</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cells mediate maternal tolerance to the fetus</article-title>
          <source>Nat Immun</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>266</fpage>
          <lpage>71</lpage>
        </element-citation>
      </ref>
      <ref id="b36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asseman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fowler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Powrie</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Control of experimental inflammatory bowel disease by regulatory T cells</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2000</year>
          <volume>162</volume>
          <fpage>S185</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11029392</pub-id>
        </element-citation>
      </ref>
      <ref id="b37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Demengeot</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>CD25 + CD4 + regulatory T cells suppress CD4 + T cell-mediated pulmonary hyperinflammation driven by <italic>Pneumocystis carinii</italic> in immunodeficient mice</article-title>
          <source>Eur J Immunol</source>
          <year>2002</year>
          <volume>32</volume>
          <fpage>1282</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">11981815</pub-id>
        </element-citation>
      </ref>
      <ref id="b38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kullberg</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Jankovic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gorelick</surname>
              <given-names>PL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bacteria-triggered CD4(+) T regulatory cells suppress <italic>Helicobacter hepaticus</italic>-induced colitis</article-title>
          <source>J Exp Med</source>
          <year>2002</year>
          <volume>196</volume>
          <fpage>505</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">12186842</pub-id>
        </element-citation>
      </ref>
      <ref id="b39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baecher-Allan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Viglietta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hafler</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of human CD4(+)CD25(+high) regulatory T cell function</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>169</volume>
          <fpage>6210</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">12444126</pub-id>
        </element-citation>
      </ref>
      <ref id="b40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oldenhove</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>de Heusch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Urbain-Vansanten</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CD4 + CD25 + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo</article-title>
          <source>J Exp Med</source>
          <year>2003</year>
          <volume>198</volume>
          <fpage>259</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">12874259</pub-id>
        </element-citation>
      </ref>
      <ref id="b41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNeill</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Spittle</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Backstrom</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61</article-title>
          <source>Scand J Immunol</source>
          <year>2007</year>
          <volume>65</volume>
          <fpage>63</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17212768</pub-id>
        </element-citation>
      </ref>
      <ref id="b42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Read</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Malmstrom</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Powrie</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation</article-title>
          <source>J Exp Med</source>
          <year>2000</year>
          <volume>192</volume>
          <fpage>295</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">10899916</pub-id>
        </element-citation>
      </ref>
      <ref id="b43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tagami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4</article-title>
          <source>J Exp Med</source>
          <year>2000</year>
          <volume>192</volume>
          <fpage>303</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">10899917</pub-id>
        </element-citation>
      </ref>
      <ref id="b44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McHugh</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Whitters</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Piccirillo</surname>
              <given-names>CA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor</article-title>
          <source>Immunity</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>311</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">11869690</pub-id>
        </element-citation>
      </ref>
      <ref id="b45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Workman</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Flies</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Role of LAG-3 in regulatory T cells</article-title>
          <source>Immunity</source>
          <year>2004</year>
          <volume>21</volume>
          <fpage>503</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">15485628</pub-id>
        </element-citation>
      </ref>
      <ref id="b46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seddiki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Santner-Nanan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Martinson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells</article-title>
          <source>J Exp Med</source>
          <year>2006</year>
          <volume>203</volume>
          <fpage>1693</fpage>
          <lpage>700</lpage>
          <pub-id pub-id-type="pmid">16818676</pub-id>
        </element-citation>
      </ref>
      <ref id="b47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Putnam</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Xu-Yu</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 + T reg cells</article-title>
          <source>J Exp Med</source>
          <year>2006</year>
          <volume>203</volume>
          <fpage>1701</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">16818678</pub-id>
        </element-citation>
      </ref>
      <ref id="b48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Control of regulatory T cell development by the transcription factor Foxp3</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>1057</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">12522256</pub-id>
        </element-citation>
      </ref>
      <ref id="b49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontenot</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Gavin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells</article-title>
          <source>Nat Immun</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>330</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="b50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khattri</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yasayko</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Ramsdell</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>An essential role for Scurfin in CD4 + CD25 + T regulatory cells</article-title>
          <source>Nat Immun</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>337</fpage>
          <lpage>42</lpage>
        </element-citation>
      </ref>
      <ref id="b51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robb</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Munck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>T cell growth factor receptors. Quantitation, specificity, and biological relevance</article-title>
          <source>J Exp Med</source>
          <year>1981</year>
          <volume>154</volume>
          <fpage>1455</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">6975347</pub-id>
        </element-citation>
      </ref>
      <ref id="b52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iyoda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tarbell</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Direct expansion of functional CD25 + CD4 + regulatory T cells by antigen-processing dendritic cells</article-title>
          <source>J Exp Med</source>
          <year>2003</year>
          <volume>198</volume>
          <fpage>235</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">12874257</pub-id>
        </element-citation>
      </ref>
      <ref id="b53">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allan</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Crome</surname>
              <given-names>SQ</given-names>
            </name>
            <name>
              <surname>Crellin</surname>
              <given-names>NK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production</article-title>
          <source>Int Immunol</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>345</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">17329235</pub-id>
        </element-citation>
      </ref>
      <ref id="b54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walunas</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Lenschow</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>CY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CTLA-4 can function as a negative regulator of T cell activation</article-title>
          <source>Immunity</source>
          <year>1994</year>
          <volume>1</volume>
          <fpage>405</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">7882171</pub-id>
        </element-citation>
      </ref>
      <ref id="b55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nocentini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Giunchi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ronchetti</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1997</year>
          <volume>94</volume>
          <fpage>6216</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">9177197</pub-id>
        </element-citation>
      </ref>
      <ref id="b56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Triebel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jitsukawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baixeras</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>LAG-3, a novel lymphocyte activation gene closely related to CD4</article-title>
          <source>J Exp Med</source>
          <year>1990</year>
          <volume>171</volume>
          <fpage>1393</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="pmid">1692078</pub-id>
        </element-citation>
      </ref>
      <ref id="b57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baixeras</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Huard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Miossec</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens</article-title>
          <source>J Exp Med</source>
          <year>1992</year>
          <volume>176</volume>
          <fpage>327</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">1380059</pub-id>
        </element-citation>
      </ref>
      <ref id="b58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aerts</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Dombrecht</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Ebo</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Bridts</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>De Clerck</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis</article-title>
          <source>Cell Immunol</source>
          <year>2008</year>
          <volume>251</volume>
          <fpage>109</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">18538752</pub-id>
        </element-citation>
      </ref>
      <ref id="b59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Loss of IL-7 receptor alpha on CD4 + T cells defines terminally differentiated B cell-helping effector T cells in a B cell-rich lymphoid tissue</article-title>
          <source>J Immunol</source>
          <year>2007</year>
          <volume>179</volume>
          <fpage>7448</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">18025189</pub-id>
        </element-citation>
      </ref>
      <ref id="b60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontenot</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Rasmussen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Dooley</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Farr</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cell lineage specification by the forkhead transcription factor foxp3</article-title>
          <source>Immunity</source>
          <year>2005</year>
          <volume>22</volume>
          <fpage>329</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">15780990</pub-id>
        </element-citation>
      </ref>
      <ref id="b61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>van Bilsen</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Bakker</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Expression of FOXP3 mRNA is not confined to CD4 + CD25 + T regulatory cells in humans</article-title>
          <source>Hum Immunol</source>
          <year>2005</year>
          <volume>66</volume>
          <fpage>13</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">15620457</pub-id>
        </element-citation>
      </ref>
      <ref id="b62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roncador</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Maestre</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of FOXP3 protein expression in human CD4 + CD25 + regulatory T cells at the single-cell level</article-title>
          <source>Eur J Immunol</source>
          <year>2005</year>
          <volume>35</volume>
          <fpage>1681</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">15902688</pub-id>
        </element-citation>
      </ref>
      <ref id="b63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ioan-Facsinay</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>van der Voort</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Huizinga</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Toes</surname>
              <given-names>RE</given-names>
            </name>
          </person-group>
          <article-title>Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells</article-title>
          <source>Eur J Immunol</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>129</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="pmid">17154262</pub-id>
        </element-citation>
      </ref>
      <ref id="b64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>DQ</given-names>
            </name>
            <name>
              <surname>Ramsey</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Induction of FOXP3 expression in naive human CD4 + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>110</volume>
          <fpage>2983</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">17644734</pub-id>
        </element-citation>
      </ref>
      <ref id="b65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pillai</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Karandikar</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Transient regulatory T-cells: a state attained by all activated human T-cells</article-title>
          <source>Clin Immunol</source>
          <year>2007</year>
          <volume>123</volume>
          <fpage>18</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">17185041</pub-id>
        </element-citation>
      </ref>
      <ref id="b66">
        <label>66</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thornton</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>CD4 + CD25 + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production</article-title>
          <source>J Exp Med</source>
          <year>1998</year>
          <volume>188</volume>
          <fpage>287</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">9670041</pub-id>
        </element-citation>
      </ref>
      <ref id="b67">
        <label>67</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takahashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kuniyasu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Toda</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunologic self-tolerance maintained by CD25 + CD4 + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state</article-title>
          <source>Int Immunol</source>
          <year>1998</year>
          <volume>10</volume>
          <fpage>1969</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">9885918</pub-id>
        </element-citation>
      </ref>
      <ref id="b68">
        <label>68</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szymczak-Workman</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Workman</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Vignali</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress</article-title>
          <source>J Immunol</source>
          <year>2009</year>
          <volume>182</volume>
          <fpage>5188</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">19380762</pub-id>
        </element-citation>
      </ref>
      <ref id="b69">
        <label>69</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haury</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Coutinho</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Demengeot</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Specificity requirements for selection and effector functions of CD25 + 4 + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>8213</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">12034883</pub-id>
        </element-citation>
      </ref>
      <ref id="b70">
        <label>70</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Henriksen</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes</article-title>
          <source>J Exp Med</source>
          <year>2004</year>
          <volume>199</volume>
          <fpage>1455</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">15184499</pub-id>
        </element-citation>
      </ref>
      <ref id="b71">
        <label>71</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarbell</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Toy</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Steinman</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>CD25 + CD4 + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes</article-title>
          <source>J Exp Med</source>
          <year>2004</year>
          <volume>199</volume>
          <fpage>1467</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">15184500</pub-id>
        </element-citation>
      </ref>
      <ref id="b72">
        <label>72</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tonkin</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Barbour</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Haskins</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo</article-title>
          <source>J Immunol</source>
          <year>2008</year>
          <volume>181</volume>
          <fpage>4516</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">18802054</pub-id>
        </element-citation>
      </ref>
      <ref id="b73">
        <label>73</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huter</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Stummvoll</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>DiPaolo</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease</article-title>
          <source>J Immunol</source>
          <year>2008</year>
          <volume>181</volume>
          <fpage>8209</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">19050237</pub-id>
        </element-citation>
      </ref>
      <ref id="b74">
        <label>74</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Homann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Holz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bot</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autoreactive CD4 + T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway</article-title>
          <source>Immunity</source>
          <year>1999</year>
          <volume>11</volume>
          <fpage>463</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">10549628</pub-id>
        </element-citation>
      </ref>
      <ref id="b75">
        <label>75</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gregg</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>174</volume>
          <fpage>6772</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">15905518</pub-id>
        </element-citation>
      </ref>
      <ref id="b76">
        <label>76</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanchot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vasseur</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pontoux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sarukhan</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Immune regulation by self-reactive T cells is antigen specific</article-title>
          <source>J Immunol</source>
          <year>2004</year>
          <volume>172</volume>
          <fpage>4285</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">15034042</pub-id>
        </element-citation>
      </ref>
      <ref id="b77">
        <label>77</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Tooley</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice</article-title>
          <source>Nat Immun</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>83</fpage>
          <lpage>92</lpage>
        </element-citation>
      </ref>
      <ref id="b78">
        <label>78</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kappler</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Roehm</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marrack</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>T cell tolerance by clonal elimination in the thymus</article-title>
          <source>Cell</source>
          <year>1987</year>
          <volume>49</volume>
          <fpage>273</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">3494522</pub-id>
        </element-citation>
      </ref>
      <ref id="b79">
        <label>79</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blackman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Gerhard-Burgert</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Woodland</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kappler</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Marrack</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A role for clonal inactivation in T cell tolerance to Mls-1a</article-title>
          <source>Nature</source>
          <year>1990</year>
          <volume>345</volume>
          <fpage>540</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">1971916</pub-id>
        </element-citation>
      </ref>
      <ref id="b80">
        <label>80</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGuirk</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>McCann</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis</article-title>
          <source>J Exp Med</source>
          <year>2002</year>
          <volume>195</volume>
          <fpage>221</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">11805149</pub-id>
        </element-citation>
      </ref>
      <ref id="b81">
        <label>81</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montagnoli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bacci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bozza</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>B7/CD28-dependent CD4 + CD25 + regulatory T cells are essential components of the memory-protective immunity to <italic>Candida albicans</italic></article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>169</volume>
          <fpage>6298</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">12444136</pub-id>
        </element-citation>
      </ref>
      <ref id="b82">
        <label>82</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belkaid</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Piccirillo</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Mendez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sacks</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>CD4 + CD25 + regulatory T cells control Leishmania major persistence and immunity</article-title>
          <source>Nature</source>
          <year>2002</year>
          <volume>420</volume>
          <fpage>502</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">12466842</pub-id>
        </element-citation>
      </ref>
      <ref id="b83">
        <label>83</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suffia</surname>
              <given-names>IJ</given-names>
            </name>
            <name>
              <surname>Reckling</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Piccirillo</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Goldszmid</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Belkaid</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Infected site-restricted Foxp3 + natural regulatory T cells are specific for microbial antigens</article-title>
          <source>J Exp Med</source>
          <year>2006</year>
          <volume>203</volume>
          <fpage>777</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">16533885</pub-id>
        </element-citation>
      </ref>
      <ref id="b84">
        <label>84</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Maurik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Herber</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: CD4 + CD25 + alloantigen-specific immunoregulatory cells that can prevent CD8 + T cell-mediated graft rejection: implications for anti-CD154 immunotherapy</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>169</volume>
          <fpage>5401</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">12421913</pub-id>
        </element-citation>
      </ref>
      <ref id="b85">
        <label>85</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ochando</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Yopp</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3 + regulatory T cells</article-title>
          <source>J Immunol</source>
          <year>2005</year>
          <volume>174</volume>
          <fpage>6993</fpage>
          <lpage>7005</lpage>
          <pub-id pub-id-type="pmid">15905542</pub-id>
        </element-citation>
      </ref>
      <ref id="b86">
        <label>86</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jordan</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Boesteanu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>AJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thymic selection of CD4 + CD25 + regulatory T cells induced by an agonist self-peptide</article-title>
          <source>Nat Immun</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>301</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="b87">
        <label>87</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawahata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Misaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamauchi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>4399</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="pmid">11970982</pub-id>
        </element-citation>
      </ref>
      <ref id="b88">
        <label>88</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Apostolou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sarukhan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>von Boehmer</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Origin of regulatory T cells with known specificity for antigen</article-title>
          <source>Nat Immun</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>756</fpage>
          <lpage>63</lpage>
        </element-citation>
      </ref>
      <ref id="b89">
        <label>89</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Santen</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Benoist</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mathis</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells</article-title>
          <source>J Exp Med</source>
          <year>2004</year>
          <volume>200</volume>
          <fpage>1221</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">15534371</pub-id>
        </element-citation>
      </ref>
      <ref id="b90">
        <label>90</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tyznik</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Self</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Liggitt</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Recognition of the peripheral self by naturally arising CD25 + CD4 + T cell receptors</article-title>
          <source>Immunity</source>
          <year>2004</year>
          <volume>21</volume>
          <fpage>267</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">15308106</pub-id>
        </element-citation>
      </ref>
      <ref id="b91">
        <label>91</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsieh</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fontenot</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires</article-title>
          <source>Nat Immun</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>401</fpage>
          <lpage>10</lpage>
        </element-citation>
      </ref>
      <ref id="b92">
        <label>92</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Obst</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Correia-Neves</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Losyev</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mathis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Benoist</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4 + T cells</article-title>
          <source>J Immunol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>7032</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">17513752</pub-id>
        </element-citation>
      </ref>
      <ref id="b93">
        <label>93</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pacholczyk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Iwashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kraj</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ignatowicz</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Nonself-antigens are the cognate specificities of Foxp3 + regulatory T cells</article-title>
          <source>Immunity</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>493</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">17869133</pub-id>
        </element-citation>
      </ref>
      <ref id="b94">
        <label>94</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stephens</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Foxp3 + regulatory T cells: selfishness under scrutiny</article-title>
          <source>Immunity</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>417</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17892850</pub-id>
        </element-citation>
      </ref>
      <ref id="b95">
        <label>95</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mosmann</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Cherwinski</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Bond</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Giedlin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Coffman</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins</article-title>
          <source>J Immunol</source>
          <year>1986</year>
          <volume>136</volume>
          <fpage>2348</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">2419430</pub-id>
        </element-citation>
      </ref>
      <ref id="b96">
        <label>96</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrington</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Hatton</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Mangan</surname>
              <given-names>PR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages</article-title>
          <source>Nat Immun</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>1123</fpage>
          <lpage>32</lpage>
        </element-citation>
      </ref>
      <ref id="b97">
        <label>97</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>XO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17</article-title>
          <source>Nat Immun</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>1133</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="b98">
        <label>98</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nurieva</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hwang</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</article-title>
          <source>Immunity</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>138</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">18599325</pub-id>
        </element-citation>
      </ref>
      <ref id="b99">
        <label>99</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vogelzang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McGuire</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sprent</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mackay</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A fundamental role for interleukin-21 in the generation of T follicular helper cells</article-title>
          <source>Immunity</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>127</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">18602282</pub-id>
        </element-citation>
      </ref>
      <ref id="b100">
        <label>100</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gajewski</surname>
              <given-names>TF</given-names>
            </name>
            <name>
              <surname>Fitch</surname>
              <given-names>FW</given-names>
            </name>
          </person-group>
          <article-title>Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones</article-title>
          <source>J Immunol</source>
          <year>1988</year>
          <volume>140</volume>
          <fpage>4245</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">2967332</pub-id>
        </element-citation>
      </ref>
      <ref id="b101">
        <label>101</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandez-Botran</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Mosmann</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Vitetta</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells</article-title>
          <source>J Exp Med</source>
          <year>1988</year>
          <volume>168</volume>
          <fpage>543</fpage>
          <lpage>58</lpage>
          <pub-id pub-id-type="pmid">2970518</pub-id>
        </element-citation>
      </ref>
      <ref id="b102">
        <label>102</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swain</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Weinberg</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>English</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Huston</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>IL-4 directs the development of Th2-like helper effectors</article-title>
          <source>J Immunol</source>
          <year>1990</year>
          <volume>145</volume>
          <fpage>3796</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="pmid">2147202</pub-id>
        </element-citation>
      </ref>
      <ref id="b103">
        <label>103</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brinkmann</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Alkan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heusser</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Interferon alpha increases the frequency of interferon gamma-producing human CD4 + T cells</article-title>
          <source>J Exp Med</source>
          <year>1993</year>
          <volume>178</volume>
          <fpage>1655</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">8228812</pub-id>
        </element-citation>
      </ref>
      <ref id="b104">
        <label>104</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Connor</surname>
              <given-names>W</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Kamanaka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Booth</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A protective function for interleukin 17A in T cell-mediated intestinal inflammation</article-title>
          <source>Nat Immun</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>603</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="b105">
        <label>105</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wurster</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Rodgers</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Satoskar</surname>
              <given-names>AR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells</article-title>
          <source>J Exp Med</source>
          <year>2002</year>
          <volume>196</volume>
          <fpage>969</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">12370258</pub-id>
        </element-citation>
      </ref>
      <ref id="b106">
        <label>106</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yssel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>De Waal Malefyt</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Roncarolo</surname>
              <given-names>MG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IL-10 is produced by subsets of human CD4 + T cell clones and peripheral blood T cells</article-title>
          <source>J Immunol</source>
          <year>1992</year>
          <volume>149</volume>
          <fpage>2378</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">1356125</pub-id>
        </element-citation>
      </ref>
      <ref id="b107">
        <label>107</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Del Prete</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>De Carli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Almerigogna</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Giudizi</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Biagiotti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Romagnani</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production</article-title>
          <source>J Immunol</source>
          <year>1993</year>
          <volume>150</volume>
          <fpage>353</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">8419468</pub-id>
        </element-citation>
      </ref>
      <ref id="b108">
        <label>108</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Assenmacher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Radbruch</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells</article-title>
          <source>Eur J Immunol</source>
          <year>1994</year>
          <volume>24</volume>
          <fpage>1097</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">7910138</pub-id>
        </element-citation>
      </ref>
      <ref id="b109">
        <label>109</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Oukka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuchroo</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Sacks</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis</article-title>
          <source>J Exp Med</source>
          <year>2007</year>
          <volume>204</volume>
          <fpage>285</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">17283207</pub-id>
        </element-citation>
      </ref>
      <ref id="b110">
        <label>110</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Madan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Karp</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Braciale</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10</article-title>
          <source>Nat Med</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>277</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">19234462</pub-id>
        </element-citation>
      </ref>
      <ref id="b111">
        <label>111</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Powrie</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Carlino</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leach</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Mauze</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Coffman</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4 + T cells</article-title>
          <source>J Exp Med</source>
          <year>1996</year>
          <volume>183</volume>
          <fpage>2669</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">8676088</pub-id>
        </element-citation>
      </ref>
      <ref id="b112">
        <label>112</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coffman</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Lebman</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Shrader</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes</article-title>
          <source>J Exp Med</source>
          <year>1989</year>
          <volume>170</volume>
          <fpage>1039</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">2788703</pub-id>
        </element-citation>
      </ref>
      <ref id="b113">
        <label>113</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sonoda</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hitoshi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production</article-title>
          <source>J Exp Med</source>
          <year>1989</year>
          <volume>170</volume>
          <fpage>1415</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">2677210</pub-id>
        </element-citation>
      </ref>
      <ref id="b114">
        <label>114</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Vlasselaer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Punnonen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-beta directs IgA switching in human B cells</article-title>
          <source>J Immunol</source>
          <year>1992</year>
          <volume>148</volume>
          <fpage>2062</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">1347548</pub-id>
        </element-citation>
      </ref>
      <ref id="b115">
        <label>115</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McIntyre</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Klinman</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells</article-title>
          <source>J Exp Med</source>
          <year>1993</year>
          <volume>177</volume>
          <fpage>1031</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">8459202</pub-id>
        </element-citation>
      </ref>
      <ref id="b116">
        <label>116</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satoguina</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Adjobimey</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arndts</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta</article-title>
          <source>Eur J Immunol</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>3101</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">18924213</pub-id>
        </element-citation>
      </ref>
      <ref id="b117">
        <label>117</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Voo</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Santori</surname>
              <given-names>FR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification of IL-17-producing FOXP3 + regulatory T cells in humans</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>4793</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">19273860</pub-id>
        </element-citation>
      </ref>
      <ref id="b118">
        <label>118</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beriou</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Costantino</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Ashley</surname>
              <given-names>CW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IL-17-producing human peripheral regulatory T cells retain suppressive function</article-title>
          <source>Blood</source>
          <year>2009</year>
          <volume>113</volume>
          <fpage>4240</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19171879</pub-id>
        </element-citation>
      </ref>
      <ref id="b119">
        <label>119</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ayyoub</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Deknuydt</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Raimbaud</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human memory FOXP3 + Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>8635</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">19439651</pub-id>
        </element-citation>
      </ref>
      <ref id="b120">
        <label>120</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brunkow</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Jeffery</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Hjerrild</surname>
              <given-names>KA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>68</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">11138001</pub-id>
        </element-citation>
      </ref>
      <ref id="b121">
        <label>121</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wan</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Flavell</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>5126</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">15795373</pub-id>
        </element-citation>
      </ref>
      <ref id="b122">
        <label>122</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chatila</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Blaeser</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome</article-title>
          <source>J Clin Invest</source>
          <year>2000</year>
          <volume>106</volume>
          <fpage>R75</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">11120765</pub-id>
        </element-citation>
      </ref>
      <ref id="b123">
        <label>123</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wildin</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Ramsdell</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Peake</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>18</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">11137992</pub-id>
        </element-citation>
      </ref>
      <ref id="b124">
        <label>124</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Christie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ramsdell</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>20</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">11137993</pub-id>
        </element-citation>
      </ref>
      <ref id="b125">
        <label>125</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tivol</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Borriello</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schweitzer</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>WP</given-names>
            </name>
            <name>
              <surname>Bluestone</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
          <article-title>Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4</article-title>
          <source>Immunity</source>
          <year>1995</year>
          <volume>3</volume>
          <fpage>541</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">7584144</pub-id>
        </element-citation>
      </ref>
      <ref id="b126">
        <label>126</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waterhouse</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Penninger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Timms</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4</article-title>
          <source>Science</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>985</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">7481803</pub-id>
        </element-citation>
      </ref>
      <ref id="b127">
        <label>127</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shull</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Ormsby</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kier</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>359</volume>
          <fpage>693</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">1436033</pub-id>
        </element-citation>
      </ref>
      <ref id="b128">
        <label>128</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Sanjabi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Flavell</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms</article-title>
          <source>Immunity</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>455</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="pmid">16973386</pub-id>
        </element-citation>
      </ref>
      <ref id="b129">
        <label>129</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Rethinking the molecular definition of regulatory T cells</article-title>
          <source>Eur J Immunol</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>928</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">18395863</pub-id>
        </element-citation>
      </ref>
      <ref id="b130">
        <label>130</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gavin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rasmussen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Fontenot</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Foxp3-dependent programme of regulatory T-cell differentiation</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>771</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">17220874</pub-id>
        </element-citation>
      </ref>
      <ref id="b131">
        <label>131</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Haribhai</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Relland</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulatory T cell development in the absence of functional Foxp3</article-title>
          <source>Nat Immun</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>359</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="b132">
        <label>132</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hill</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Feuerer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tash</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature</article-title>
          <source>Immunity</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>786</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="pmid">18024188</pub-id>
        </element-citation>
      </ref>
      <ref id="b133">
        <label>133</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3</article-title>
          <source>Nat Immun</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>277</fpage>
          <lpage>84</lpage>
        </element-citation>
      </ref>
      <ref id="b134">
        <label>134</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Floess</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Freyer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Siewert</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epigenetic control of the foxp3 locus in regulatory T cells</article-title>
          <source>PLoS Biol</source>
          <year>2007</year>
          <volume>5</volume>
          <fpage>e38</fpage>
          <pub-id pub-id-type="pmid">17298177</pub-id>
        </element-citation>
      </ref>
      <ref id="b135">
        <label>135</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baron</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Floess</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wieczorek</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells</article-title>
          <source>Eur J Immunol</source>
          <year>2007</year>
          <volume>37</volume>
          <fpage>2378</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="pmid">17694575</pub-id>
        </element-citation>
      </ref>
      <ref id="b136">
        <label>136</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polansky</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Kretschmer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Freyer</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DNA methylation controls Foxp3 gene expression</article-title>
          <source>Eur J Immunol</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>1654</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">18493985</pub-id>
        </element-citation>
      </ref>
      <ref id="b137">
        <label>137</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Jeffery</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ramsdell</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ziegler</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>37672</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">11483607</pub-id>
        </element-citation>
      </ref>
      <ref id="b138">
        <label>138</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kretschmer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Frampton</surname>
              <given-names>GM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Foxp3 occupancy and regulation of key target genes during T-cell stimulation</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>931</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">17237765</pub-id>
        </element-citation>
      </ref>
      <ref id="b139">
        <label>139</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Josefowicz</surname>
              <given-names>SZ</given-names>
            </name>
            <name>
              <surname>Kas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Gavin</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>936</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">17237761</pub-id>
        </element-citation>
      </ref>
      <ref id="b140">
        <label>140</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Cobbold</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Fairchild</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen</article-title>
          <source>J Immunol</source>
          <year>2004</year>
          <volume>172</volume>
          <fpage>5900</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">15128770</pub-id>
        </element-citation>
      </ref>
      <ref id="b141">
        <label>141</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groux</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>O&#x2019;Garra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bigler</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A CD4 + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>389</volume>
          <fpage>737</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">9338786</pub-id>
        </element-citation>
      </ref>
      <ref id="b142">
        <label>142</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieira</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Minaee</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 + CD25 + regulatory T cells</article-title>
          <source>J Immunol</source>
          <year>2004</year>
          <volume>172</volume>
          <fpage>5986</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">15128781</pub-id>
        </element-citation>
      </ref>
      <ref id="b143">
        <label>143</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levings</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Gregori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tresoldi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cazzaniga</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bonini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roncarolo</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25 + CD4 + Tr cells</article-title>
          <source>Blood</source>
          <year>2005</year>
          <volume>105</volume>
          <fpage>1162</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">15479730</pub-id>
        </element-citation>
      </ref>
      <ref id="b144">
        <label>144</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>CD69 + CD4 + CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1</article-title>
          <source>J Immunol</source>
          <year>2009</year>
          <volume>182</volume>
          <fpage>111</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">19109141</pub-id>
        </element-citation>
      </ref>
      <ref id="b145">
        <label>145</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lund</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hsing</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pham</surname>
              <given-names>TT</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>AY</given-names>
            </name>
          </person-group>
          <article-title>Coordination of early protective immunity to viral infection by regulatory T cells</article-title>
          <source>Science</source>
          <year>2008</year>
          <volume>320</volume>
          <fpage>1220</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">18436744</pub-id>
        </element-citation>
      </ref>
      <ref id="b146">
        <label>146</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komatsu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mariotti-Ferrandiz</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Malissen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneity of natural Foxp3 + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2009</year>
          <volume>106</volume>
          <fpage>1903</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">19174509</pub-id>
        </element-citation>
      </ref>
      <ref id="b147">
        <label>147</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuji</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Komatsu</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawamoto</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preferential generation of follicular B helper T cells from Foxp3 + T cells in gut Peyer&#x2019;s patches</article-title>
          <source>Science</source>
          <year>2009</year>
          <volume>323</volume>
          <fpage>1488</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">19286559</pub-id>
        </element-citation>
      </ref>
      <ref id="b148">
        <label>148</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duarte</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Zelenay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bergman</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Martins</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Demengeot</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions</article-title>
          <source>Eur J Immunol</source>
          <year>2009</year>
          <volume>39</volume>
          <fpage>948</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">19291701</pub-id>
        </element-citation>
      </ref>
      <ref id="b149">
        <label>149</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 + T cells</article-title>
          <source>Immunity</source>
          <year>2009</year>
          <volume>30</volume>
          <fpage>155</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">19144320</pub-id>
        </element-citation>
      </ref>
      <ref id="b150">
        <label>150</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kitani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuss</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Strober</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: regulatory T cells induce CD4 + CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta</article-title>
          <source>J Immunol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>6725</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17513718</pub-id>
        </element-citation>
      </ref>
      <ref id="b151">
        <label>151</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>XO</given-names>
            </name>
            <name>
              <surname>Nurieva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular antagonism and plasticity of regulatory and inflammatory T cell programs</article-title>
          <source>Immunity</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>44</fpage>
          <lpage>56</lpage>
          <pub-id pub-id-type="pmid">18585065</pub-id>
        </element-citation>
      </ref>
      <ref id="b152">
        <label>152</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>453</volume>
          <fpage>236</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">18368049</pub-id>
        </element-citation>
      </ref>
      <ref id="b153">
        <label>153</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Osorio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>LeibundGut-Landmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lochner</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DC activated via dectin-1 convert Treg into IL-17 producers</article-title>
          <source>Eur J Immunol</source>
          <year>2008</year>
          <volume>38</volume>
          <fpage>3274</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">19039774</pub-id>
        </element-citation>
      </ref>
      <ref id="b154">
        <label>154</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lage</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates</article-title>
          <source>J Theor Biol</source>
          <year>2000</year>
          <volume>207</volume>
          <fpage>231</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="pmid">11034831</pub-id>
        </element-citation>
      </ref>
      <ref id="b155">
        <label>155</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carneiro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Leon</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Caramalho</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>When three is not a crowd: a Crossregulation model of the dynamics and repertoire selection of regulatory CD4 + T cells</article-title>
          <source>Immunol Rev</source>
          <year>2007</year>
          <volume>216</volume>
          <fpage>48</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="pmid">17367334</pub-id>
        </element-citation>
      </ref>
      <ref id="b156">
        <label>156</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pasare</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Medzhitov</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>1033</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">12532024</pub-id>
        </element-citation>
      </ref>
      <ref id="b157">
        <label>157</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sutmuller</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>den Brok</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Toll-like receptor 2 controls expansion and function of regulatory T cells</article-title>
          <source>J Clin Invest</source>
          <year>2006</year>
          <volume>116</volume>
          <fpage>485</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="pmid">16424940</pub-id>
        </element-citation>
      </ref>
      <ref id="b158">
        <label>158</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jonsson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ljunggren</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Natvig</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Orn</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Goran Moller 1936&#x2013;2008</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>113</fpage>
          <pub-id pub-id-type="pmid">18702740</pub-id>
        </element-citation>
      </ref>
      <ref id="b159">
        <label>159</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coutinho</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Holmberg</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Goran Moller 1936&#x2013;2008</article-title>
          <source>Scand J Immunol</source>
          <year>2008</year>
          <volume>68</volume>
          <fpage>114</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">18702741</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
